Showing results (51-60 of 270) with videos related to
Sort By:
Pageof 27
Current Opinion in Oncology|October 9, 2008
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopeniaBenjamin Levy, Jon E Arnason, James B BusselBritish Journal of Haematology|January 5, 2020
Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)Eun-Ju Lee, Marina Izak, James B BusselBritish Journal of Haematology|September 27, 2003
Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancyMarc Michel, Maria V Novoa, James B BusselBritish Journal of Haematology|September 22, 2023
The role of genetics in refractory immune thrombocytopeniaJames L Zehnder, James B Bussel, Nichola CooperBritish Journal of Haematology|May 2, 2025
The paradox of autoimmune thrombocytopenia in common variable immunodeficiencyBrit Trogen, Charlotte Cunningham-Rundles, James B BusselBlood|March 4, 2026
Anti-HPA-1a Fetal-Neonatal AlloImmune Thrombocytopenia: Reframing Diagnostics, Pathophysiology, and ManagementJames B Bussel, Jory Max Hirshman, Rick KapurHematology. American Society of Hematology. Education Program|December 5, 2025
Refractory ITP: revisiting definitions, diagnostics, and management paradigmsSandhya R Panch, Ganesh Raman, James B BusselCritical Care Clinics|April 4, 2009
Oxygen therapeutics: perfluorocarbons and blood substitute safetyClaudia S Cohn, Melissa M CushingClinical Microbiology Reviews|July 1, 2016
Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood SupplyAndrew D Johnson, Claudia S CohnAmerican Journal of Obstetrics and Gynecology|August 1, 2006
Alloimmune thrombocytopenia: state of the art 2006Richard L Berkowitz, James B Bussel, Janice G McFarlandPageof 27